Analog Devices, a high-performance semiconductor company for signal processing applications, announced plans to collaborate with LifeQ to develop technology for noninvasive biometric monitoring devices that provide physiological data with high accuracy that is currently only available through expensive, invasive surgical equipment.

The two companies plan to combine Analog Devices' industry-leading technology and innovation with LifeQ's unique biomathematics capabilities to design sensors that can continuously and accurately track physiological parameters such as heart rate, sleep stages, sleep quality, blood lactate, and 24-hour calorie intake, as well as stress indicators such as salivary cortisol. As this type of data becomes more monitorable, there will be an increase in the early detection of emergencies and diseases in at-risk patients.



“Developing smart wearable sensors is essential to supercharging the next generation of noninvasive biometric monitoring solutions,” said James Doscher, general manager, Industrial and Business Healthcare, Analog Devices. “ADI provides the semiconductor expertise, and LifeQ provides the biomathematical knowledge base needed to develop sensors that can help biometric monitoring devices more effectively prevent, predict, and manage disease. This will have a profound impact on how doctors and patients share information, interact, and make decisions about their care. This will give patients greater access to their own vital information, empowering them to take greater ownership of their overall health and wellness.”